CBD oil is legal in Maine. The state enacted Chapter 12 of the Maine Public Law 2019 (LD 630) to harmonize the state hemp laws with the Farm Bill. The law legalized the cultivation, possession, transportation, and use of hemp and hemp-derived products in the state. In the 2016 elections, Maine voters approved "Question 1" to legalize recreational marijuana for adults aged 21 years or above. The Marijuana Legalization Act was enacted to permit the cultivation, processing, transportation, sales, and use of marijuana and marijuana products, including marijuana-derived CBD. Hemp-derived CBD and cannabis-derived CBD are legal for adults aged 21 and above in the state.
The 2016 Marijuana Legalization Act (MLA) legalized the cultivation, manufacture, processing, distribution, and sales of marijuana-derived CBD to persons aged 21 years and above. The Act was amended in 2019. The Act established the Office of Marijuana Policy (OMP), under the Department of Administrative and Financial Services, to regulate and license adult-use marijuana establishments. The law permits the possession of a maximum of two and a half ounces of marijuana products, including marijuana-derived CBD. However, marijuana and marijuana products are prohibited in public spaces and federal lands such as national parks.
Chapter 12 of the Maine Public Law 2019 (LD 630) legalized the state's cultivation, manufacture, distribution, sales, and use of hemp and hemp products. The law also legalized the production and sales of food containing hemp-derived CBD. The law decriminalized the possession and use of hemp and hemp products in the state.
Per chapter 12 of the Maine Public Law 2019, there is no limit to the amount of hemp-derived CBD an adult aged 21 years and above can carry. However, the Marijuana Legalization Act limits the possession of marijuana-derived CBD to two and a half ounces for adults aged 21 years and above.
Yes, licensed doctors can prescribe CBD oil. Per the Maine Medical Use of Marijuana Act, as amended in 2019, medical providers can prescribe marijuana-derived CBD oil to treat any medical condition they deem treatable by marijuana products. The law permits a medical provider to determine the diseases and conditions that can be treated by marijuana and marijuana products in conjunction with a physician. The doctor is mandated by law to inform the patient of the risks and potential benefits of the medical use of marijuana.
Maine had adopted the law permitting the use of marijuana and marijuana products, including marijuana-derived CBD products, to treat specific medical conditions in 1999 and updated the Act in 2009. The 2009 amended Act listed certain diseases that patients must have to qualify for marijuana-based therapies. The list included diseases such as cancer, chronic pain, multiple sclerosis, seizures, AIDS, glaucoma, epilepsy, Crohn's syndrome, and Post Traumatic Stress Disorder (PTSD). The list of qualifying diseases was eliminated in the 2019 amendment, and the power to determine qualifying medical conditions lies with medical providers and doctors.
Maine requires intending buyers of CBD products to be 21 years or older. This age restriction means that CBD stores and dispensaries must ask for shoppers’ IDs and confirm their ages before selling low-THC CBD products to them.
Chapter 12 of the Maine Public Law 2019 (LD 630) permits growing up to three hemp plants by adults aged 21 years and above without a license. To grow more than three plants, a grower must obtain a license from the Department of Agriculture, Conservation and Forestry (DACF). The process for obtaining a license to grow hemp is as follows:
Maine's Office of Marijuana Policy (OMP) regulates and licenses the cultivation, manufacture, and sales of marijuana-derived CBD. All applicants for cannabis licenses go through criminal background checks to apply for conditional licenses. Applications are then submitted to the Office of Marijuana Policy (OMP) with applicable fees for non-renewable conditional licenses valid for a year. Application fees for dispensaries, manufacturers, and testing licenses are $250. Cultivation application fees are $100 for tier 1 and $500 for tiers 2 - 4.
A conditional license holder will be eligible for an "Active license" if the local municipality certifies that the applicant satisfies all local regulations and licensing requirements. The OMP will review local authorization and any updated documents. An invoice for licensing fee will be issued to the applicant if the OMP approves the application. Licensing fees for marijuana business licenses are:
Applicants for CBD business licenses must meet the following requirements:
Chapter 12 of the Maine Public Law 2019 provide the following conditions for hemp-derived CBD edible products:
Adults aged 21 years and above can legally purchase CBD oil and CBD products from dispensaries, stores, and pharmacies in the state. They can also purchase CBD-infused items at health food stores. In addition, interested persons can buy CBD products from online stores and have them delivered to their preferred locations within the state.
CBD oil is the product resulting from the admixture of CBD extract with a carrier oil. After extracting CBD from cannabis plants, it comes out as a thick paste. To formulate it into easy-to-use products and improve its shelf life, manufacturers combine this paste with a carrier oil such as hemp seed oil or coconut oil.
Cannabidiol (CBD) is the second most abundant ingredient in the cannabis plant. CBD is non-intoxicating and non-addictive. The World Health Organization (WHO) in 2017 revealed that CBD taken alone cannot be abused and can be used to lower cravings for addictive substances like heroin, alcohol, tobacco, opiates, and even cannabis. Tetrahydrocannabinol (THC) is a psychoactive, intoxicating compound and is the most abundant ingredient in the cannabis plant.
The proportion of THC present in hemp and marijuana differs even though they are both cannabis plants. Hemp is defined as the plant species Cannabis sativa and any part of the plant, including the seeds and all its derivatives, isomers, extracts, acids, cannabinoids, and salts with a total delta-9 tetrahydrocannabinol concentration of not more than 0.3% on a dry weight basis. A cannabis plant with a THC concentration of more than 0.3% is classified as cannabis or marijuana.
Hemp-derived CBD is legal in the US under the Agriculture Improvement Act. The law empowered the US Food and Drug Administration (FDA) to regulate the cultivation and use of hemp and hemp-derived products. However, cannabis-derived CBD is considered marijuana under the Controlled Substances Act and is regulated by the Drug Enforcement Administration (DEA).
Several benefits have been attributed to CBD based on test results conducted on animals and humans. Some of the supposed benefits include the treatment of the following:
The FDA approved Epidiolex to treat certain seizure types. Epidiolex is the only CBD-based drug approved by the FDA for medical use. CBD is sold in different forms such as oils, edibles, vape cartridges, topicals, tinctures, and smokable plant materials.
There are broadly three types of CBD products: full-spectrum CBD, broad-spectrum CBD, and CBD isolate (pure CBD). Full-spectrum CBD contains multiple cannabinoids, such as essential oils, terpenes, and 0.3% THC. Broad-spectrum CBD contains numerous cannabinoids and terpenes with an untraceable level or absence of THC. CBD isolate has no other cannabinoid and is sometimes called CBD crystals, it is the pure form of CBD. Cannabidiol (CBD) is available and legal in Maine.
One confirmed health benefit of CBD is its anti-seizure property. The use of CBD to treat epileptic seizures has turned into at least a product approved by the FDA. Preliminary evidence also shows that CBD may have other neuroprotective benefits and be useful in the treatment of other mental health disorders such as anxiety and depression. CBD is commonly used to treat insomnia, chronic pain, and inflammation and also to boost appetite and improve cardiovascular health.
Cannabis drug tests do not detect CBD presence in the body. However, CBD users can still fail such tests if they consume products with significant levels of THC. Cannabis drug tests detect THC and its metabolites. While most low-THC CBD products are labeled to contain no more than 0.3% THC, variations in product batches and mislabeling can lead users to ingest higher doses of THC than intended. It is also possible for regular users of full-spectrum CBD products to accumulate significant levels of THC that can be detected by drug tests.